CHEERS 2022: Global Expert Panel Publishes Updated Consolidated Health Economic Evaluation Reporting Standards

Published Jan 11, 2022

New Expanded Report Provides Guidance to Improve Reporting of Economic Evaluations of Health Interventions

Value in Health has published CHEERS 2022Lawrenceville, NJ, USA—January 11, 2022—Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of updated standards for reporting health economics research. The report, “Consolidated Health Economic Evaluation Reporting Standards 2022 Explanation and Elaboration: A Report of the ISPOR Economic Evaluation Guidelines Good Research Practices Task Force II,” is published in the January 2022 issue of Value in Health. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance.

Economic evaluations of health interventions are comparative analyses of alternative courses of action in terms of their costs and consequences. These evaluations can provide valuable information to healthcare decision makers about choices that affect health and the use of resources, such as the adoption of new drugs, devices, or procedures. Economic evaluations, however, present a reporting challenge due to the substantial information that must be conveyed to allow scrutiny of study findings. This presents the need for reporting guidance to help authors, journal editors, and peer reviewers in their identification and interpretation of economic evaluations. The CHEERS report provides healthcare stakeholders with guidance and a checklist to improve reporting.

“We and the other authors believe that this update of the CHEERS guidelines will be useful to those who need to identify, prepare, and interpret reports of health economic evaluations,” said task force chairs Don Husereau, BScPharm, MSc and Michael F. Drummond, MCom, DPhil. “Despite the promotion and increased number of available health economic evaluations, as well as the availability of the original CHEERS guidance in multiple languages, there is still some indication CHEERS could be more widely and appropriately used.”

The original CHEERS report and summary statements that were published in 2013 have been cited more than 2700 times in 9 years, making it the most highly cited of all ISPOR Good Practices Reports. The scope of CHEERS 2022 has been expanded to include all major types of economic evaluation (cost-effectiveness analysis, cost benefit analysis, and models).

The new 28-item checklist in the CHEERS 2022 report includes 4 substantially new items: (1) a health economics analysis plan, (2) a characterization of distributional effects, (3) an approach to engage with patients and others affected by the study, and (4) the impact of engagement with patients and others affected by the study.

As part of the roll-out of the new guidance, the ISPOR CHEERS II Good Practices Task Force will present a webinar on January 26, 2022, at 10:00AM EST. This webinar, led by the task force co-chairs, will focus on the main changes from the original CHEERS and provide a quick live demonstration on how to use the new guidance document. The webinar will also discuss how a patient and public participation group was involved in the revision process, the resources being developed to support CHEERS 2022, the proposals for its dissemination, and the involvement of a wide range of journals in the publication of the report. During the webinar, participants will have the opportunity to comment on the new recommendations and other topics, such as whether CHEERS 2022 would benefit from a series of user guides for the various users of published economic evaluations.

“This new reporting guidance will help authors provide accurate information on which health interventions are being compared and in what context, how the evaluation was undertaken, what the findings are, and other details that will aid readers, reviewers, and decision makers in the interpretation and use of studies,” said Drummond and Husereau. “The CHEERS 2022 reporting standards present a call to action and opportunity for the health economic community to develop comprehensive and clear reports of health economic evaluations.”

Additional information on CHEERS 2022 can be found here. Additional information on ISPOR’s Good Practices Reports and other ISPOR Reports can be found here.



ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram

Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2020 impact factor score is 5.725 and its 5-year impact factor score is 6.932. Value in Health is ranked 4th of 98 journals in health policy and services, 9th of 108 journals in healthcare sciences and services, and 24th of 376 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Website  | Twitter (@isporjournals)

ISPOR has earned an international reputation for research excellence based, in part, on its Good Practices Reports. These highly cited reports are expert consensus recommendations on good practice standards for outcomes research (clinical, economic, and patient-reported outcomes) and on the use of this research in healthcare decision making. ISPOR Task Forces comprise subject matter experts representing different stakeholders from diverse work environments (ie, regulators, payers, manufacturers, technology assessors, etc from research, government, academic, and industry sectors around the world). All ISPOR Good Practices Reports are published in the Society’s scientific journal, Value in Health, and are made freely available as part of the Society’s mission. The Society’s Good Practices Reports have been recognized with an ASAE “Power of A” award that acknowledges innovative, effective, and broad-reaching programs that have a positive impact on the world.

Related Stories

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Nov 7, 2023

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Nov 6, 2023

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now